Search
Putting Quality, Safety, and Experience On a Pedestal
As it reconfigures its practice for the future, New York Eye and Ear Infirmary of Mount Sinai (NYEE) is drawing generously on its pandemic-driven experience of the past.Helping Low-Vision Patients Lead Independent Lives
For all their hard work to preserve and restore eyesight, ophthalmologists often reach the limits of what they can accomplish with standard treatment.Two Powerful Imaging Tools Make Their Debut in the United States
Technology continues to hold center stage at New York Eye and Ear Infirmary of Mount Sinai (NYEE), underscored by the recent arrival of two cutting-edge imaging devices: a tear film analyzer and an optical coherence tomography (OCT) Doppler.More Than Meets The Eye
Esen Akpek, M.D., the Bendann Family Professor of Ophthalmology and chief of the Ocular Surface Disease Clinic at Wilmer Eye Institute, is a world-renowned expert in the evaluation and treatment of dry eye disease.NYEE-Mount Sinai Eye Stroke Protocol Saves a Young Woman’s Sight
Treatment of acute eye stroke with intra-arterial tPA is showing great promiseInherited Retinal and Choroidal Dystrophies
Daniel Chung, DO, a senior investigator at the Scheie Eye Institute at Penn Medicine, offers an overview of the inherited retinal and choroidal dystrophies, and discusses their diagnosis and pathology.Ophthalmology Staff & Services Directory
Visit mayoclinic.org/medicalprofs for more information | The medical professionals page offers physician-specific information including open clinical trials, CME events, and e-newsletters covering the latest in diagnosis and treatments.Ophthalmic Pathology Referral Service at New York Eye and Ear Infirmary of Mount Sinai
The Ophthalmic Pathology Referral Service at New York Eye and Ear Infirmary of Mount Sinai is meeting a critical need for ophthalmic pathology services regionally and nationallyMalignant Ocular Melanoma
Joan O’Brien, MD, offers an overview of ocular melanoma and the ways in which genetic profiling is permitting personalized approaches to the treatment of the disease.BroadcastMed Launches New Platform for Vision Portfolio of Products
Surgical Transplantation of Human RPE Stem Cell-Derived RPE Monolayers into Non-Human Primates with Immunosuppression
Science is one step closer to developing effective cell therapy to treat blindness. Mount Sinai’s researchers recently published paper found that retinal cells from a human cadaver’s eye could be successfully transplanted into primate eyes, offering a potential treatment for blindnessOpen-Angle Glaucoma
Eydie Miller-Ellis, MD, assesses the characteristics and types of open-angle glaucoma across case studies across risk factors, causes, and symptoms.